793 related articles for article (PubMed ID: 28814457)
21. Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists.
Auer E; Frey S; Kaesmacher J; Hakim A; Seiffge DJ; Goeldlin M; Arnold M; Fischer U; Jung S; Meinel TR
J Neurol; 2019 Sep; 266(9):2263-2272. PubMed ID: 31165232
[TBL] [Abstract][Full Text] [Related]
22. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
[TBL] [Abstract][Full Text] [Related]
23. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
[TBL] [Abstract][Full Text] [Related]
24. Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage.
Chen SJ; Yeh SJ; Tang SC; Lin SY; Tsai LK; Jeng JS
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):106-112. PubMed ID: 30876786
[TBL] [Abstract][Full Text] [Related]
25. Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.
Tsivgoulis G; Katsanos AH; Seiffge DJ; Paciaroni M; Wilson D; Koga M; Macha K; Cappellari M; Kallmünzer B; Polymeris AA; Toyoda K; Caso V; Werring DJ; Engelter ST; De Marchis GM;
Eur J Neurol; 2020 Aug; 27(8):1612-1617. PubMed ID: 32333493
[TBL] [Abstract][Full Text] [Related]
26. Resumption of Direct Oral Anticoagulants in Patients with Acute Spontaneous Intracerebral Hemorrhage.
Kato Y; Hayashi T; Suzuki K; Maruyama H; Kikkawa Y; Kurita H; Takao M
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104292. PubMed ID: 31375402
[TBL] [Abstract][Full Text] [Related]
27. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
28. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
[TBL] [Abstract][Full Text] [Related]
30. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
31. Acute Ischemic Stroke Outcome and Preceding Anticoagulation: Direct Oral Anticoagulants Versus Vitamin K Antagonists.
Tavares SF; Ferreira I; Chaves V; Flores L; Correia C; Almeida J; Fonseca L; Castro Chaves P
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104691. PubMed ID: 32067853
[TBL] [Abstract][Full Text] [Related]
32. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
[TBL] [Abstract][Full Text] [Related]
33. The dose of direct oral anticoagulants and outcomes of intracerebral hemorrhage: Preliminary findings.
Suzuki K; Kato Y; Hayashi T; Maruyama H; Kikkawa Y; Kurita H
Clin Neurol Neurosurg; 2018 Nov; 174():63-67. PubMed ID: 30216809
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.
Seiffge DJ; Goeldlin MB; Tatlisumak T; Lyrer P; Fischer U; Engelter ST; Werring DJ
J Neurol; 2019 Dec; 266(12):3126-3135. PubMed ID: 31541341
[TBL] [Abstract][Full Text] [Related]
35. Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events.
Seiffge DJ; Traenka C; Polymeris A; Hert L; Peters N; Lyrer P; Engelter ST; Bonati LH; De Marchis GM
Neurology; 2016 Nov; 87(18):1856-1862. PubMed ID: 27694266
[TBL] [Abstract][Full Text] [Related]
36. Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
Ha FJ; Barra S; Brown AJ; Begley DA; Grace AA; Agarwal S
Int J Cardiol; 2018 Jul; 262():51-56. PubMed ID: 29606512
[TBL] [Abstract][Full Text] [Related]
37. Safety and effectiveness of direct oral anticoagulants versus vitamin K antagonists: results from 3 Italian regions.
Kirchmayer U; Narduzzi S; Mayer F; Tuccori M; Leoni O; Belleudi V; Di Martino M; Lallo A; Addis A; Davoli M
Recenti Prog Med; 2019 Apr; 110(4):195-202. PubMed ID: 31066365
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
39. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study.
Zanella L; Zoppellaro G; Marigo L; Denas G; Padayattil Jose S; Pengo V
Cardiovasc Ther; 2018 Oct; 36(5):e12458. PubMed ID: 30007110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
